PROVIDER PROFILE · NPI 1043301773
Ekta OhriD.O.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
213
Beneficiaries
—
Total drug cost
$79K
Distinct drugs
14
Brand share
50.7%
Top prescribed drugs
Empagliflozin27 claims
Levothyroxine Sodium23 claims
Furosemide19 claims
Fenofibrate Nanocrystallized16 claims
Metformin Hcl16 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE